Needle Free Diabetes Care Market to Grow with a CAGR of 15.49% through 2028
Technological advancements, improved adherence, and
heightened awareness are expected to drive the Global Needle Free Diabetes Care
Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Needle Free
Diabetes Care Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Needle Free Diabetes Care Market
stood at USD 13.51 billion in 2022 and is anticipated to grow with a CAGR of 15.49%
in the forecast period, 2024-2028. This can be attributed to awareness and
education. There has been a growing awareness of the importance of diabetes
management and the availability of innovative treatment options. Diabetes
organizations, healthcare providers, and pharmaceutical companies have been
actively educating both patients and healthcare professionals about the
benefits of needle-free solutions. This increased awareness has contributed to
the adoption of these technologies.
Moreover, the global needle-free diabetes care market
is expanding beyond traditional markets like North America and Europe. Emerging
economies with growing diabetes populations are becoming important players in
this market. Companies are increasingly focusing on tailoring their products
and solutions to meet the needs of diverse global populations.
Insulin therapy is the primary treatment for diabetes
when oral hypoglycemic agents prove ineffective in managing type 2 diabetes.
This treatment is typically administered via submucosal injections for both
type 1 and type 2 diabetes patients. During diagnosis, the conventional method
of monitoring blood glucose levels involves pricking the skin, which can lead
to needle-stick injuries for healthcare professionals, posing risks of
infections and discomfort. Consequently, individuals are turning to non-invasive,
needle-free diabetes products.
The growth of the needle-free diabetes care market is
significantly propelled by the introduction of transdermal patches that can
measure blood sugar levels through the skin without the need for blood
extraction. This innovation is driven by factors such as the increasing
adoption of unhealthy lifestyles, including the consumption of junk food
worldwide, and the rising prevalence of obesity. Moreover, the market benefits
from heightened awareness about diabetes and its treatments, as well as ongoing
technological advancements aimed at improving treatment options. Additionally,
factors like a growing elderly population, higher incidence of diabetes,
changing lifestyles, and increased healthcare spending all contribute
positively to the expansion of the needle-free diabetes care market.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Needle Free Diabetes Care Market.”
The Global Needle Free Diabetes Care Market is
segmented into device type, end user, regional
distribution, and company.
Based on its device type, Insulin pumps are poised to
dominate the Global Needle-Free Diabetes Care Market in 2022 due to their
compelling advantages over traditional insulin injection methods. These
cutting-edge devices offer precise and continuous insulin delivery, allowing
for better blood glucose control and improved quality of life for diabetes
patients. The convenience of needle-free administration not only reduces the
pain associated with injections but also eliminates the need for multiple daily
injections, leading to increased patient compliance. Moreover, insulin pumps
enable healthcare professionals to remotely monitor and adjust insulin dosages,
providing personalized care and reducing the risk of complications. As
technology continues to advance, insulin pumps are expected to integrate even
more sophisticated features, further solidifying their position as the
preferred choice in diabetes management, thus driving their dominance in the
global market.
Based on region, North America is positioned to
dominate the Global Needle-Free Diabetes Care Market in 2022 for several
compelling reasons. Firstly, the region boasts a well-established healthcare
infrastructure and a high prevalence of diabetes, which drives demand for
advanced diabetes management solutions. Moreover, the North American market
benefits from robust research and development activities, fostering innovation
in needle-free diabetes care technology. Additionally, favorable reimbursement
policies and a strong focus on patient-centric healthcare contribute to the
rapid adoption of these advanced devices. Furthermore, a proactive regulatory
environment ensures that new needle-free diabetes care products can swiftly
enter the market, positioning North America as a hub for innovation and market
leadership in this sector. With a combination of high demand, innovative
capabilities, and supportive healthcare policies, North America is poised to
maintain its dominance in the Global Needle-Free Diabetes Care Market.
Major companies operating in Global Needle Free
Diabetes Care Market are:
- 3M Co
- Bioject Medical Technologies Inc
- Valeritas Inc
- Antares Pharma Inc
- Endo International PLC
- InsuJet
- Pharmajet Inc
- INJEX Pharma AG
- Johnson & Johnson
- MannKind Corp
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The global needle-free diabetes care market is
evolving at a rapid pace, driven by technological advancements, patient-centric
approaches, and a growing emphasis on personalized care. The upcoming trends
represent the direction in which this market is heading, promising improved
diabetes management and enhanced quality of life for individuals living with
diabetes. As thes trends continue to unfold, stakeholders in the healthcare
industry, including patients, providers, and manufacturers, will need to adapt
to a changing landscape to ensure that the potential benefits are fully
realized,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Needle Free Diabetes Care Market By Device
Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet
Injectors), By End User (Homecare, Diagnostic Center, Hospitals & Clinic), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Needle Free Diabetes Care Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Needle Free Diabetes Care Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com